US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Dec 16, 2022 (4 years ago)

Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications

What was recalled

Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01

Recalling firm
Aurolife Pharma, LLC
NDC code
13107-014-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0087-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all